Guggenheim cuts Kroger stock price target to $66 on volume weakness
Source: Investing.com

Guggenheim cut Kroger's price target to $66 from $71, citing weak food volumes and reduced full-year comparable-sales guidance, while retaining a Buy rating. Kroger's fiscal Q2 adjusted EPS of $1.09 beat the $1.06 consensus, but revenue of $34.6 billion narrowly missed the $34.65 billion forecast and identical-sales growth remained weak. The firm lowered its 2026-27 EBIT estimates, though it expects Cyclospora normalization and company self-help actions to improve results over the next three to four months; shares rose about 3% on Friday.
Analysis
KR’s relative resilience after lower sales expectations is more important than the modest EPS beat: the market is underwriting self-help and valuation support while ignoring that weak unit volumes impair the operating leverage needed to sustain margin expansion. With fuel near $4/gallon, lower-income grocery baskets face a two-sided squeeze—less discretionary spend and greater trip-consolidation—which favors Walmart (WMT) and Costco (COST) where fuel, general merchandise and membership economics create a stronger value proposition. KR’s private-label mix can cushion gross margin, but it cannot fully offset fixed-store labor, shrink and distribution costs if traffic remains soft.
Over the next 1-3 months, the key question is whether management’s anticipated normalization is visible in weekly traffic and identical-sales trends rather than merely in promotional comparisons. Consensus cuts may limit downside at a low EBITDA multiple, but a further sales-guide reduction would expose the stock to a value-trap rerating: EBIT estimates have already moved lower, and incremental cuts would make the apparent multiple less inexpensive. The 6-18 month structural issue is competitive: WMT’s price investments and digital fulfillment scale could force KR to reinvest in value, transferring any procurement gains back to customers rather than shareholders.
Contrarian view: KR is not an obvious short solely on weak demand. A low multiple, durable dividend capacity and credible cost actions can make it a defensible defensive holding if volumes stabilize; the better expression is relative, not directional. The thesis is falsified positively by sequential traffic improvement and maintained EBIT guidance at the next update; it is falsified negatively by another comparable-sales reduction, worsening gross-margin rate, or evidence that price gaps versus WMT are widening.
AllMind Terminal
AI-powered research, real-time alerts, and portfolio analytics for institutional investors.
Request TrialMarket Sentiment
Overall Sentiment
mixed
Sentiment Score
-0.18
Ticker Sentiment
Key Decisions for Investors
- Avoid adding outright KR ahead of the next sales/traffic update; use $58-$60 as a watch zone only if management reiterates EBIT guidance and sequential identical-sales trends improve. A renewed guidance cut would justify reassessing for downside rather than averaging down.
- Initiate a 3-6 month pair trade: long WMT / short KR in equal dollar amounts. The trade captures value-seeking share shift and WMT’s broader basket/fuel advantage; target 8-12% relative return, with a stop if KR demonstrates two consecutive periods of improving traffic while WMT’s U.S. comparable-sales momentum decelerates materially.
- For existing KR longs, sell upside exposure into a recovery toward the revised analyst target area rather than treating the dividend as sufficient compensation for estimate risk. Retain only a reduced position pending independently observable weekly volume or market-share data.
- Monitor regional gasoline prices, SNAP/consumer-spending data, and WMT grocery comparable sales over the next 4-8 weeks. Sustained fuel inflation without corresponding food deflation increases KR’s traffic and promotional-risk skew; rapid fuel normalization would remove a near-term bearish catalyst.
More News
- Novo Nordisk rebrands as ’Novo’, announces cultural reset
- Deckers Outdoor Corporation stock hits 52-week low at $78.91
- Chip, memory stocks fall amid calls for AI development slowdown
- Truist raises Scholar Rock stock price target on SMA drug approval
- Why is SanDisk stock sliding today?
- Anthropic tells investors it will post second straight quarterly profit